Literature DB >> 19346457

Effect of ATP-sensitive potassium channel agonists on sympathetic hyperinnervation in postinfarcted rat hearts.

Chih-Sen Kang1, Chien-Chang Chen, Chih-Chan Lin, Nen-Chung Chang, Tsung-Ming Lee.   

Abstract

Although the acute administration of ATP-sensitive potassium (K(ATP)) channel agonists provides a neuroprotection, it is unclear whether similar benefits are found by modulating sympathetic innervation in chronic settings after myocardial infarction. We assessed whether K(ATP) channel agonists can attenuate the sprouting of cardiac sympathetic nerves after infarction. Male Wistar rats after ligating coronary artery were randomized to either saline, nicorandil, pinacidil, glibenclamide, or a combination of 1) nicorandil and glibenclamide or 2) pinacidil and glibenclamide for 4 wk. To elucidate the role of mitochondrial K(ATP) channels in modulating nerve growth factor, 5-hydroxydecanoate was assessed in an in vitro model. The measurement of myocardial norepinephrine levels revealed a significant elevation in saline-treated infarcted rats compared with sham-operated rats, consistent with excessive sympathetic innervation. Excessive sympathetic innervation was blunted after giving the rats either nicorandil or pinacidil, compared with saline, as assessed by the immunohistochemical analysis of tyrosine hydroxylase, growth associated protein-43, and neurofilament and Western blot analysis and real-time quantitative RT-PCR of nerve growth factor. The arrhythmic scores during programmed stimulation in the saline- or glibenclamide-treated infarcted rats were significantly higher than those of rats treated with K(ATP) channel agonists. In contrast, the beneficial effects of nicorandil and pinacidil were abolished by administering either glibenclamide or 5-hydroxydecanoate. The sympathetic hyperinnervation after infarction is attenuated by the activation of mitochondrial K(ATP) channels. The chronic use of mitochondrial K(ATP) channel agonists after infarction may attenuate the arrhythmogenic response to programmed electrical stimulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19346457     DOI: 10.1152/ajpheart.00903.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  15 in total

1.  Incomplete reprogramming after fusion of human multipotent stromal cells and bronchial epithelial cells.

Authors:  Ingrid M Curril; Masayo Koide; Calvin H Yang; Alan Segal; George C Wellman; Jeffrey L Spees
Journal:  FASEB J       Date:  2010-08-19       Impact factor: 5.191

2.  Effects of adding intravenous nicorandil to standard therapy on cardiac sympathetic nerve activity and myocyte dysfunction in patients with acute decompensated heart failure.

Authors:  Shu Kasama; Takuji Toyama; Ryuichi Funada; Noriaki Takama; Norimichi Koitabashi; Shuichi Ichikawa; Yasuyuki Suzuki; Naoya Matsumoto; Yuichi Sato; Masahiko Kurabayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-30       Impact factor: 9.236

3.  The effect of nicorandil on small intestinal ischemia-reperfusion injury in a canine model.

Authors:  Yujin Suto; Kiyohiro Oshima; Kazuhisa Arakawa; Hiroaki Sato; Hodaka Yamazaki; Koshi Matsumoto; Izumi Takeyoshi
Journal:  Dig Dis Sci       Date:  2011-03-01       Impact factor: 3.199

Review 4.  Use of nicorandil in cardiovascular disease and its optimization.

Authors:  Shigeo Horinaka
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

5.  Inhibition of N-type calcium channels in cardiac sympathetic neurons attenuates ventricular arrhythmogenesis in heart failure.

Authors:  Dongze Zhang; Huiyin Tu; Chaojun Wang; Liang Cao; Wenfeng Hu; Bryan T Hackfort; Robert L Muelleman; Michael C Wadman; Yu-Long Li
Journal:  Cardiovasc Res       Date:  2021-01-01       Impact factor: 10.787

Review 6.  Cardiac Effects of Phosphodiesterase-5 Inhibitors: Efficacy and Safety.

Authors:  Sumon Roy; Robert A Kloner; Fadi N Salloum; Ion S Jovin
Journal:  Cardiovasc Drugs Ther       Date:  2021-10-15       Impact factor: 3.947

7.  Effects of statin therapy on cardiac sympathetic nerve activity and left ventricular remodeling in patients with chronic heart failure: a propensity score-matched analysis.

Authors:  Hirokazu Sano; Shu Kasama; Shinichiro Fujimoto; Takuji Toyama; Noriaki Takama; Norimichi Koitabashi; Shuichi Ichikawa; Yasuyuki Suzuki; Naoya Matsumoto; Yuichi Sato; Masahiko Kurabayashi
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

8.  Targeted NGF siRNA delivery attenuates sympathetic nerve sprouting and deteriorates cardiac dysfunction in rats with myocardial infarction.

Authors:  Hesheng Hu; Yongli Xuan; Ye Wang; Mei Xue; Fei Suo; Xiaolu Li; Wenjuan Cheng; Xinran Li; Jie Yin; Ju Liu; Suhua Yan
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

9.  K ATP channel agonists preserve connexin43 protein in infarcted rats by a protein kinase C-dependent pathway.

Authors:  Tsung-Ming Lee; Chih-Chan Lin; Hsiao-Yin Lien; Chien-Chang Chen
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

10.  Correlation of Ventricular Arrhythmogenesis with Neuronal Remodeling of Cardiac Postganglionic Parasympathetic Neurons in the Late Stage of Heart Failure after Myocardial Infarction.

Authors:  Dongze Zhang; Huiyin Tu; Chaojun Wang; Liang Cao; Robert L Muelleman; Michael C Wadman; Yu-Long Li
Journal:  Front Neurosci       Date:  2017-05-08       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.